US-listed companies
Royalty Pharma plc

Royalty Pharma plcRPRX

Market cap

$16.9B

P/E ratio

14.9x

Income statement Balance sheet Cash flow

	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023
Cash and cash equivalents	1,009	1,541	1,711	477
Marketable securities	983	582	24	-
Financial royalty assets	587	614	691	738
Accrued royalty receivable	33	53	17	14
Available for sale debt securities	70	66	1	18
Other royalty income receivable	6	15	20	22
Other current assets	9	7	91	4
Total current assets	2,697	2,878	2,555	1,274
Financial royalty assets, net	12,368	13,718	13,493	14,089
Intangible royalty assets, net	29	6	-	-
Equity securities	299	270	112	199
Equity securities	299	270	112	199
Available for sale debt securities	144	204	226	437
Available for sale debt securities	144	204	226	437
Equity method investments	455	435	397	376
Equity method investments	455	435	397	376
Other assets	23	4	30	7
Other assets	23	4	30	7
Total assets	16,020	17,516	16,813	16,382
Total assets	16,020	17,516	16,813	16,382
Due to Related Parties, Current	126	108	95	-
Distributions payable to legacy non-controlling interests	-	-	-	83
Accounts payable and accrued expenses	11	6	8	15
Interest payable	42	58	54	52
Current portion of long-term debt	-	-	998	-
Other current liabilities	-	-	12	11
Total current liabilities	308	171	1,167	161
Long-term debt	5,817	7,096	6,119	6,135
Other liabilities	-	-	3	1
Total liabilities	6,124	7,267	7,288	6,298
Class A Ordinary Shares	0	0	0	0
Class R Redeemable Shares	0	0	0	0
Additional paid-in capital	2,866	3,508	3,666	4,011
Retained earnings	1,921	2,255	1,965	2,518
Non-controlling interests	5,077	4,472	3,897	3,558
Accumulated other comprehensive income	34	16	-	-
Treasury interests	2	3	3	3
Treasury interests	2	3	3	3
Class A Ordinary Shares	0	0	0	0
Class R Redeemable Shares	0	0	0	0
Total shareholders’ equity	9,896	10,249	9,525	10,084
Class A Ordinary Shares	0	0	0	0
Class R Redeemable Shares	0	0	0	0
Total shareholders’ equity	9,896	10,249	9,525	10,084
Total liabilities and shareholders’ equity	16,020	17,516	16,813	16,382